NNOX

Nano-X Imaging Ltd.

Nasdaq· X-Ray Apparatus & Tubes & Related Irradiation Apparatus· Inc. L3· CIK 0001795251 Healthcare & Medical Devices

$0.3430 −0.03 (−8.04%)

Oct 26 4:00 PM ET · prev $0.3730

Market cap

$30.1M

Nano cap

Consensus

Buy

78% Buy or better · 9 analysts

Median target

$4.40

+1183% · range $3.00–5.00

Next earnings

Nov 19

in 23 days · EPS est. −$0.14

1 year

−91.5%

from $4.03 · Oct 27

30 days

−45.7%

from $0.6320

52-week range

$0.3430–4.55

at the low

Avg volume 20D

869.4K

Oct 19 spike 2.41M

Short interest

🔒 Subscribers only

Insider net

+$189.5K

3 buyers · 1 seller · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 8 reports · 90 days

Balance 6 bearish · 0 bullish · 2 neutral oldest → newest, height = score

Avg score

·High conf. 7/8 ·Next Earnings date, Nov 19, 2026

Strongest BEARISH Nano-X Imaging reported preliminary Q3 2026 revenue of $4.3-4.4M (up from $3.4M YoY), driven by AI/software…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

S Jun 10 1 insider sell $1.1K at $1.65
A Jul 7 Alliance Global Partners downgrades
R Jul 23 Nano-X Imaging reported preliminary Q2 2026 revenue of $4.0-$4.1M (u…
B Jul 27 to Jul 28 2 days of insider buys: $109.7K by 3 insiders, avg $0.9217
B Aug 10 1 insider buy $9.7K at $1.03
B Sep 10 to Sep 15 3 days of insider buys: $60.0K by 2 insiders, avg $0.7500
R Oct 16 Nano-X Imaging reported preliminary Q3 2026 revenue of $4.3-4.4M (up…
B Oct 19 1 insider buy $11.3K at $0.4500

Signal stack

Where each data set points today.

InsidersBULLISH

3 insiders bought $190.7K at an average $0.8167. 1 insider sold $1.1K. Price is 58% below their cost.
InstitutionsBEARISH

Q2 2026: 11 added (0 new), 18 trimmed or exited.
AnalystsBULLISH

7 of 9 rate it Buy or better. Every target is above the price.
EstimatesFALLING

Current-quarter EPS estimate −$0.110 → −$0.140 over 90 days. 0 up, 1 down in 30 days.
TrendDOWNTREND

50% below its 50-day average. New closing low $0.3430 on Oct 26.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
MORGAN STANLEY	ADD	654,808	$759.6K
BlackRock, Inc.	NEAR_EXIT	596,033	$691.4K
SUSQUEHANNA INTERNATIONAL GROUP, LLP	DOUBLED	325,312	$377.4K
STATE STREET CORP	NEAR_EXIT	280,989	$325.9K
BNP PARIBAS FINANCIAL MARKETS	DOUBLED	271,601	$315.1K
ROYAL BANK OF CANADA	ADD	246,231	$285.0K
BARCLAYS PLC	DOUBLED	146,814	$170.3K
IEQ CAPITAL, LLC	ADD	99,553	$115.5K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts

Buy 78% rate it Buy or better

Strong Buy3Buy4Hold2Sell0Strong Sell0

12-month targets · 3 analysts

$0.3430 $3.00 $4.40 $5.00

Price is below the lowest target. Median implies +1183%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Aug 17, 2026	Cantor Fitzgerald REITERATE	REITERATE	Overweight
Jul 7, 2026	Alliance Global Partners DOWNGRADE	DOWNGRADE	Neutral

Insider ledger

Form 4

$190.7K

bought · 3 insiders

$1.1K

sold · 1 insider

−58.0%

vs their $0.8167 cost

Date	Insider	Type	Value
Oct 19, 2026	Meltzer Erez Chief Executive Officer	BUY	$11.3K
Oct 14, 2026	Nathansohn Guy Chief Financial Officer	AWARD	50,000 sh
Oct 14, 2026	saban sharon General Manager AI Division	AWARD	28,283 sh
Oct 14, 2026	Yahav Attias Gali Chief Corporate Resources	AWARD	28,283 sh
Oct 13, 2026	Gofman Feler Marina Chief Legal Officer	AWARD	28,283 sh
Oct 11, 2026	Dara James GM Source & Services Division	AWARD	28,283 sh
Oct 11, 2026	Aharon Cohen Tamar EVP & Chief Marketing Officer	AWARD	28,283 sh
Oct 10, 2026	Koren Ofir General Manager, ARC Division	AWARD	28,283 sh

Earnings setup

Estimates

Nov 19

reports in 23 days

−$0.14

EPS estimate, this quarter

−27%

estimate change, 90 days

0↑ 1↓

revisions, 30 days

Current-quarter EPS estimate

−$0.110

90d

−$0.100

60d

−$0.100

30d

−$0.100

−$0.140

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.14	-$0.14–-$0.14	-40.0%	$5.5M
Next Q	-$0.14	-$0.14–-$0.14	-40.0%	$7.5M
Current FY	-$0.60	-$0.60–-$0.60	-25.0%	$22.3M
Next FY	-$0.40	-$0.40–-$0.40	-33.3%	$41.5M

Short side

FINRA· Oct 15, 2026

🔒 Subscribers only

shares short

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 19, 2026 Insider

Meltzer Erez bought 25,000 shares

Chief Executive Officer @ $0.4500 ($11.3K)

Oct 16, 2026 SEC

Nano-X Imaging reported preliminary Q3 2026 revenue of $4.3-4.4M (up from $3.4M YoY), driven by AI/software growth…

6-K — Impact 7/10

Oct 16, 2026 SEC

Nano-X Imaging released preliminary Q3 2026 revenue guidance of $4.3-$4.4M (up from $3.4M YoY) but disclosed that cash…

PRESS-RELEASE — Impact 7/10

Oct 16, 2026 Earnings

Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 2026

Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for third

Oct 14, 2026 Insider

Nathansohn Guy was granted 50,000 shares

Chief Financial Officer

Oct 14, 2026 Insider

saban sharon was granted 28,283 shares

General Manager AI Division

Oct 2, 2026 SEC

Nano-X Imaging received a Nasdaq deficiency notice on September 28, 2026, because its ordinary shares traded below…

6-K — Impact 7/10

Aug 18, 2026 Press

Nano-X Imaging subsidiary Nanox AI signed a three-year exclusive sales reseller agreement with Vertec Scientific Ltd…

Impact 4/10

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Upcoming

Nov 19, 2026

Earnings date

NNOX Q3 2026 Earnings Scheduled — 2026-11-19

Recent

Oct 16, 2026

Earnings

Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 2026

Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for third Quarter Ended September 30, 2026...

Oct 15, 2026

Press release

Nanox Selected as One of TIME’s Best Inventions of 2026 for its Nanox.ARC X

Nanox.ARC X recognized among the “world’s most groundbreaking innovations” and for its approach to making advanced medical imaging more accessible ...

Oct 5, 2026

Listing

Listing Status: NNOX — Deficient (was Normal)

NANO-X IMAGING LTD - Ordinary Shares | Nasdaq Financial Status Indicator N → D

Sep 10, 2026

Press release

Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

Agreement with SOLME RC, SA Marks the third Latin American market this year

Sep 9, 2026

Earnings

Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates